Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Combining Multikinase Tyrosine Kinase Inhibitors Targeting the Vascular Endothelial Growth Factor and Cluster of Differentiation 47 Signaling Pathways Is Predicted to Increase the Efficacy of Antiangiogenic Combination Therapies

ACS Pharmacology & Translational Science(2023)10.1021/acsptsci.3c00008Source: DataRank Database

Combining Multikinase Tyrosine Kinase Inhibitors Targeting the Vascular Endothelial Growth Factor and Cluster of Differentiation 47 Signaling Pathways Is Predicted to Increase the Efficacy of Antiangiogenic Combination Therapies is a research paper published in ACS Pharmacology & Translational Science (2023). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 1.66)OA: greenTopics (16)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Aleksander S. Popel ORCID,Hojjat Bazzazi ORCID,Yu Zhang ORCID

Live enrichment

PubMed:37200806 PMC:PMC10186363 OpenAlex:https://openalex.org/W4366259800

National Institutes of Health

Grant: R01CA138264

National Institutes of Health

Grant: U01CA212007

FWCI

1.66

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

2026

greenLicense: https://doi.org/10.15223/policy-029

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10186363/pdf/pt3c00008.pdf

publisherhttps://pubs.acs.org/doi/pdf/10.1021/acsptsci.3c00008

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10186363

journalhttps://doi.org/10.1021/acsptsci.3c00008

Fields of Study

Angiogenesis and VEGF in CancerCancer Mechanisms and TherapyCancer, Hypoxia, and Metabolism

Keywords

AngiogenesisCancer researchVascular endothelial growth factorMAPK/ERK pathwaySignal transductionTumor microenvironmentKinase insert domain receptorCell biologyReceptor tyrosine kinaseKinaseVascular endothelial growth factor ABiologyVascular endothelial growth inhibitor

Sustainable Development Goals

SDG 0: Good health and well-being